Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardio-Renal Division Acting Director To Be Throckmorton; Lipicky Retires

Executive Summary

Deputy Director Douglas Throckmorton, MD, will be acting director of FDA's Division of Cardio-Renal Drug Products starting Feb. 28, when long-time Division Director Raymond Lipicky, MD, retires

You may also be interested in...



Can Drugs Really Treat Sarcopenia? Some Patients Are Doubtful

Companies developing treatments for sarcopenia ‘have no idea what they're doing’, according to Ray Lipicky, a former director of the FDA’s Cardio-Renal Drug Products Division who spoke as a patient at the US agency’s sarcopenia drug development meeting.

FDA Standards Should Emphasize Larger Trials, Lipicky Tells ACC

FDA should move toward the Cardio-Renal Drug Products Division's requirement for extremely large trials as an approval standard, former Division Director Raymond Lipicky, MD, said

FDA Standards Should Emphasize Larger Trials, Lipicky Tells ACC

FDA should move toward the Cardio-Renal Drug Products Division's requirement for extremely large trials as an approval standard, former Division Director Raymond Lipicky, MD, said

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS039320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel